Published in Women's Health Weekly, March 24th, 1997
The test measures the levels of thymidine kinase (TK) in a patients blood. The enzyme is produced by several types of cancer. For years scientists have been studying the relationship between elevated TK levels and several types of cancer, including leukemia and prostate, lung, brain, and bone cancer.
BYU microbiologist Kim O'Neill said that the test doesn't specifically detect breast cancer, but could be used to detect malignancy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.